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Abstract Proliferation and cell cycle progression of eukaryotic
cells are closely linked to changes in chromatin structure and
gene expression. By reversible histone acetylation the cell is able
to modulate chromatin condensation and accessibility of specific
regions within the chromatin. Here, we examined histone H4
acetylation patterns during growth induction of the murine
interleukin-2 dependent T cell line B6.1. In order to detect
acetylation on each of the four potential target residues we
produced a set of antibodies recognizing specifically acetylated
lysine 5, 8, 12 and 16 in the N-terminal tail of histone H4.
Acetylation was generally low in resting T cells, but increased
after stimulation with a specific kinetics for each lysine. Lysine
16 was acetylated during the G1 phase and deacetylated during S
phase. H4 acetylation on lysine 5, 8 and 12, in contrast, was
induced before cells started to replicate, and persisted until cells
entered mitosis. Treatment of resting B6.1 cells with the specific
deacetylase inhibitor trichostatin A (TSA) led to H4 hyperace-
tylation at all four lysine residues indicating that the histone
modification can occur in the absence of replication. After
release from TSA treatment normal H4 acetylation levels were
reestablished by extremely rapid deacetylation of lysines 5, 8, 12
and 16. The deacetylation step was 60^100 times faster than
TSA induced acetylation and equally efficient in resting and
exponentially growing T cells. Our results indicate the presence
of cell cycle regulated lysine specific acetylating and deacetylat-
ing activities in mouse T cells.
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1. Introduction
Reversible acetylation of the four nucleosomal core histones
H2A, H2B, H3 and H4 plays an important role in chromatin
structure and gene expression. Highly conserved lysine resi-
dues within the N-terminal domains of core histones are the
targets for this modi¢cation. The level of histone acetylation is
controlled by histone acetyltransferases and histone deacetyl-
ases. There is compelling evidence for a link between tran-
scriptionally active chromatin and histone acetylation (re-
viewed in [1^7]). Recently it was shown that transcriptional
regulators repress transcription by recruiting histone deacetyl-
ases to speci¢c promoters [8^18]. In addition the transcrip-
tional repressor MeCP2 that binds to methylated DNA has
been found to be associated with histone deacetylase activity
[19,20].
Previously we identi¢ed mouse histone deacetylase 1
(HDAC1) by di¡erential display as a growth factor inducible
gene in murine T cells [21]. The levels of HDAC1 mRNA,
protein and enzyme activity increased when resting lympho-
cytes were growth-stimulated by interleukin-2 (IL-2). Several
biological processes like spherulation of the slime mold Physa-
rum polycephalum [22], and spermatogenesis in rat [23], trout
[24], rooster [25] and Drosophila [26] are accompanied by
changes in histone acetylation levels. Furthermore, studies in
P. polycephalum revealed cell cycle speci¢c di¡erences in the
acetylation patterns of core histones [27,28]. In particular
changes in the acetylation levels of speci¢c H4 lysine residues
were shown to be crucial for certain cellular processes like
silencing [29], chromatin assembly [30,31], X chromosome in-
activation [32], mitosis [33^35] and transcriptional regulation
of speci¢c genes [36]. Therefore we examined how histone H4
acetylation changes during the re-entry of resting T cells into
the cell cycle. Antibodies directed against acetylated lysines in
the N-terminal tail of core histones have been shown to serve
as excellent tools to analyze histone acetylation in a variety of
cellular systems [33,37^41].
To study lysine site speci¢c acetylation we raised antibodies
against four short peptides representing parts of the N-termi-
nal tail of histone H4, each mono-acetylated at lysine 5, 8, 12
or 16. Using this set of site speci¢c H4 acetyllysine antibodies
we analyzed in this report H4 acetylation in T cells during the
re-entry into the cell cycle. Our study reveals di¡erent kinetics
for the acetylation and deacetylation of the four target lysine
residues and signi¢cant di¡erences in the e⁄ciency between
acetylation and deacetylation in resting T cells.
2. Materials and methods
2.1. Cell culture and media
B6.1 is an IL-2 dependent cytolytic mouse T cell line [42]. Cells were
grown in Dulbecco’s modi¢ed Eagle’s medium supplemented with 5%
heat inactivated fetal calf serum, 50 mM 2-mercaptoethanol, 10 mM
L-glutamine, and 100 U/ml of recombinant IL-2 (generous gift from
M. Nabholz, ISREC, Switzerland). To arrest B6.1 cells IL-2 was
removed from the medium for 30 h. Growth arrest and re-entry
into the cell cycle during IL-2 stimulation were monitored by £uores-
cence activated cell sorter (FACS) analysis using a Partec PAS-II
sorter. To induce histone hyperacetylation in arrested B6.1 cells the
medium was supplemented with 20 ng/ml and 40 ng/ml trichostatin A
(Wako Pure Chemical Industries) or 5 mM sodium butyrate. HeLa
cells were treated with 5 mM sodium butyrate for 24 h.
2.2. Histone isolation
Cells were harvested by centrifugation at 700Ug and washed once
with ice-cold PBS. The pellet was resuspended in 1 ml lysis bu¡er
(10 mM Tris-HCl pH 6.5, 50 mM sodium disul¢te, 10 mM MgCl2,
10 mM sodium butyrate, 8.6% sucrose, 1% Triton X-100) and centri-
fuged at 1000Ug. After three washes in lysis bu¡er the pellet was
resuspended in 10 mM Tris-HCl pH 7.4, 13 mM EDTA. After this
wash the pellet was resuspended in cold distilled water and H2SO4
was added to 0.4 N ¢nal concentration. Incubation on ice for 1 h was
followed by a centrifugation at 10 000Ug for 5 min. From the super-
natant total histones were precipitated with 10U volumes of acetone
at 320‡C overnight. The precipitated histones were collected by cen-
trifugation, dried and resuspended in distilled water.
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2.3. Peptides and antibodies
To obtain speci¢c antibodies directed against each acetylated lysine
residue in the N-terminal tail of histone H4, the following peptides
were used for the immunization of rabbits: anti-acetyllysine 5: H2N-
SGR GacKG GKG LYC-CONH2 (K5); anti-acetyllysine 8: H2N-
SGR GKG GacKG LGK YC-CONH2 (K8); anti-acetyllysine 12:
H2N-GKG LGacK GGA KYC-CONH2 (K12); anti-acetyllysine 16:
H2N-GLG KGG AacKR HYC-CONH2 (K16).
The peptides were used to immunize rabbits by standard immuno-
logical techniques (Eurogentec, Seraing, Belgium). The corresponding
antibodies were named K5, K8, K12 and K16, respectively. For af-
¢nity puri¢cation 1 mg of the corresponding peptide was coupled to a
SulfoLink column (Pierce). Antiserum (1 ml) was loaded on the col-
umn and bound antibodies were eluted with 100 mM glycine pH 2.5.
Each fraction (1 ml) was bu¡ered with 50 Wl of 1 M sodium phos-
phate pH 8.0 and supplemented with sodium azide (0.02% ¢nal con-
centration).
2.4. Western blot analysis
Equal amounts of histones (5^10 Wg) were electrophoresed on a
SDS-18% polyacrylamide gel. Gels were blotted on nitrocellulose
membranes and detected by Western blot analysis using an ECL kit
(NEN) as previously described [21].
3. Results and discussion
3.1. Preparation and characterization of antisera
In order to study histone H4 acetylation on each of the
potential target sites we raised antisera against acetyllysines
5, 8, 12 and 16. The corresponding antibodies were named
K5, K8, K12 and K16, respectively. As shown in Fig. 1A,
antibodies obtained from rabbits immunized with short pep-
tides of H4 are highly speci¢c for the corresponding mono-
acetylated peptides. No cross-reaction between these four
antibodies was detected by dot-blot analysis. In addition, all
four antibodies were speci¢c for acetylated H4 isoforms since
a non-acetylated peptide encompassing residues 1^18 of his-
tone H4 was not recognized by any of the antibodies (data not
shown). To test if the antibodies also recognize the acetylated
lysines on histone H4 protein, Western blots with HeLa his-
tones isolated before and after treatment with sodium buty-
rate were incubated with each antibody. All four antibodies
recognized hyperacetylated H4 histones from butyrate treated
cells with higher a⁄nity than H4 histones from untreated cells
(Fig. 1B). In addition antibodies K5, K8 and K12 have been
shown to recognize mono-, di-, tri- and tetra-acetylated H4
histone from chicken erythrocytes (D. Koºlle et al., submitted).
None of the a⁄nity-puri¢ed antibodies recognized other his-
tones or non-histone proteins in whole cell extracts (data not
shown). Thus, the four antibodies are suitable for studies of
lysine site speci¢c H4 acetylation patterns.
3.2. H4 acetylation during IL-2 induction of resting B6.1 cells
Previously we showed that murine HDAC1 is an IL-2 in-
ducible gene in B6.1 cells. HDAC1 protein levels and enzy-
matic activity both were up-regulated during T cell activation.
Therefore we asked if the increased histone deacetylase activ-
ity correlates with changes in general H4 acetylation pattern
during the IL-2 induction of resting T cells. B6.1 cells were
arrested by IL-2 deprivation for 30 h and restimulated with
recombinant IL-2 for di¡erent periods of time. Re-entry of
resting T cells into the cell cycle was monitored by FACS
analysis (Fig. 2B). In IL-2 deprived B6.1 cells H4 acetylation
on all four lysine residues was low (Fig. 2A). Growth stimu-
lation by IL-2 led to cell cycle phase speci¢c changes in H4
acetylation patterns. Acetyllysine 16 levels increased early and
peaked during G1 phase, 4 h after IL-2 addition. When B6.1
cells started to replicate steady state acetylation levels of lysine
16 decreased and stayed low from mid-S phase to mitosis.
Lysine residues 8 and 12 were acetylated with comparable
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Fig. 1. Speci¢city of rabbit polyclonal antibodies against acetylated
lysine residues of histone H4. A: Dot blot analysis of the di¡erent
H4 antibodies. The four peptides (2 ng) used for immunization were
spotted on nitrocellulose membranes and probed with the di¡erent
antisera. B: Western blot analysis using a⁄nity to hyperacetylated
histone H4. Equal amounts (10 Wg) of histones isolated from HeLa
cells before (3) and after (+) treatment with the deacetylase inhibi-
tor butyrate were transferred to a nitrocellulose membrane and de-
tected with the H4 speci¢c antibodies as indicated.
Fig. 2. Changes in histone H4 acetylation pattern during IL-2 stim-
ulation of murine T cells. B6.1 cells were arrested by IL-2 depriva-
tion for 30 h and restimulated with fresh medium containing 100 U/
ml recombinant IL-2 for di¡erent periods of time (indicated in
hours). Total histones were isolated at indicated time points. A:
Equal amounts of histones were separated on a SDS-18% polyacryl-
amide gel and blotted on nitrocellulose. Staining of the membrane
with Ponceau S indicated that the 12 h lane contained slightly less
histone. The membrane was sequentially incubated with antibodies
directed against acetylated lysine 5 (K5), 8 (K8), 12 (K12) and 16
(K16) of histone H4. B: FACS analysis of the DNA content of
B6.1 cells during IL-2 stimulation.
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kinetics reaching the highest levels at the beginning of the S
phase 9 h after IL-2 stimulation. Lysine 5 showed delayed
acetylation kinetics with maximal acetylation between 9 and
15 h after IL-2 stimulation corresponding to the S phase.
These ¢ndings are in good agreement with the previously
observed S phase speci¢c acetylation of de novo synthesized
H4 on lysines 5 and 12 [43] and recently published data that
showed sequential acetylation of lysines 8 and 5 by HAT-B
enzymes from maize and rat liver [44]. H4 isoforms acetylated
on lysines 5, 8 and 12 (but not on lysine 16) were also found
to be associated with the chromatin assembly factor CAF-1
[30]. Interestingly the preferred order of acetylation for H4
lysine residues during the onset of proliferation was similar
to that found by Turner and colleagues [33] in human cells
after treatment with the histone deacetylase inhibitor butyrate.
Acetylation levels of lysines 5 and 8 decreased between mid-S
phase and mitosis with the order lysine 8 followed by lysine 5,
while lysine 12 acetylation stayed high throughout the remain-
ing part of the cell cycle. This result suggests the presence of
lysine site speci¢c deacetylating activities during late S phase
of the cell cycle.
3.3. TSA induced hyperacetylation of histone H4 in resting
B6.1 cells
Next we asked if growth arrest by IL-2 deprivation a¡ects
the capability of histone acetyltransferases to modify all four
lysine residues in the N-terminal domain of histone H4. B6.1
cells were arrested by removal of IL-2 from the culture me-
dium and histone deacetylase activities were blocked by the
speci¢c inhibitor TSA [45]. H4 acetylation on lysines 12 and
16 started to rise 1 h after TSA addition followed by acetyl-
ation on lysines 5 and 8 (2 h after TSA addition) to reach
maximum levels after 9 h TSA treatment (Fig. 3A). Longer
incubation with the histone deacetylase inhibitor in the ab-
sence of IL-2 led to a dramatic reduction of the viability of
B6.1 cells (data not shown). Similar acetylation kinetics in
B6.1 cells were observed by inhibiting histone deacetylation
with sodium butyrate (J. Taplick, unpublished observations).
Our results demonstrate that by blocking deacetylating activ-
ities hyperacetylation on all four lysine residues can be in-
duced in non-replicating T cells. The H4 hyperacetylation
occurs in the absence of de novo histone synthesis and there-
fore seems to be catalyzed by nuclear histone acetyltransfer-
ases. To investigate if TSA induced histone hyperacetylation
has an e¡ect on growth arrest, we monitored the DNA con-
tent with FACS analysis. As shown in Fig. 3B, B6.1 cells
showed no detectable change in the G0 DNA pro¢le in the
absence of IL-2.
3.4. Deacetylation of hyperacetylated histone H4 in resting and
cycling B6.1 cells
Finally, we compared the acetylation levels for speci¢c H4
lysine residues in resting and cycling B6.1 cells after TSA
release. Histone hyperacetylation was induced in IL-2 de-
prived and exponentially growing cells by treatment with
TSA (40 ng/ml) for 4 h and H4 acetylation was examined
after removal of TSA from the culture medium. As shown
in Fig. 4 all four lysine residues of the H4 N-terminal tail
were deacetylated within 30 min after TSA release. In arrested
cells deacetylation at lysine 5, 12 and 16 started 5 min after
TSA was withdrawn. Acetyl residues were most e⁄ciently
removed from lysine 5 followed by lysines 12 and 16, while
lysine 8 was deacetylated with delayed kinetics between 20 and
30 min after TSA release. In exponentially growing cells H4
deacetylation was slightly slower, starting around 20 min after
TSA release with similar kinetics for lysine 5, 12 and 16. As in
arrested cells lysine 8 was the last residue that was deacety-
lated. These small di¡erences in the deacetylation process be-
tween G0 cells and cycling cells might re£ect the presence of
higher acetylating activity in proliferating cells. It is intriguing
how fast deacetylation occurs when the enzyme inhibitor TSA
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Fig. 4. H4 deacetylation kinetics after TSA release in arrested and
exponentially growing B6.1 cells. IL-2 deprived (arr) and exponen-
tially growing (exp) cells were treated with 40 ng/ml TSA for 4 h.
The medium was then replaced by fresh TSA-free medium and cells
were harvested at the indicated time points. Acetylated H4 histones
were detected by Western blot analysis using antibodies directed
against individual acetyllysine residues. The lane with histones from
exponentially growing B6.1 cells 10 min after TSA release was
slightly overloaded.
Fig. 3. TSA induced hyperacetylation of H4 histones in resting B6.1
cells. A: B6.1 cells were IL-2 starved for 30 h followed by addition
of 20 ng/ml TSA to the medium. At di¡erent time points (indicated
in hours) histones were isolated and analyzed on a Western blot
with acetyllysine speci¢c antibodies. B: FACS pro¢le of resting B6.1
cells during TSA incubation.
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is removed. In G0 cells removal of the acetyl residues is about
60^100 times faster than the hyperacetylation during TSA
treatment. Since TSA induced hyperacetylation is an arti¢cial
condition for the cell, it might be important for the eukaryotic
cell to restore normal acetylation levels.
This would indicate that the control of steady state levels of
histone acetylation by an intracellular balance between acety-
lating and deacetylating activities is crucial for eukaryotic
cells. This idea is supported by the fact that overexpression
of histone deacetylases [21,46] or inhibition of a histone ace-
tyltransferase function [47] has serious consequences for cell
growth and cell cycle progression. The data also suggest that
histone deacetylases are very e¡ective even in the absence of
growth factors and can be quickly activated by this control
system. It also raises the question if and how the cells remem-
ber the default acetylation state of chromatin both long range
and on particular nucleosomes within speci¢c promoters. This
cellular memory might be linked to factors that recognize the
acetylation of core histones and/or to the methylation of ge-
nomic DNA [19,20,48].
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